Pfizer Buys King Pharma for $3.6 Billion

With King in its fold, Pfizer -- which makes Lyrica and Celebrex -- believes it can build an industry-leading portfolio of pain relievers. Among King's most appealing entrants in that market is the new Embeda, designed to prevent misuse and abuse.

New Gmail feature fights phishing

For a while Google has been protecting users of its popular Gmail service from phishing e-mails by rejecting any message it knows is fake from...